Condition: Prostate Cancer · Sponsor: EDAP TMS S.A.
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The aim of the registry is to gather real-life data to evaluate the clinical performance and safety of medical devices in patients who have been treated with HIFU thank to the Focal One device for their prostate cancer.
This description comes directly from the study's public registry record.
Djamila BENNAT · +33 472153150 · dbennat@edap-tms.com
Léa GUEDJ · lguedj@edap-tms.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Being treated for prostate cancer with the Focal One device * Patient does not object and consent\* to the collection of clinical data in the registry Exclusion Criteria: * Patient deprived of liberty following a judicial or administrative decision * Patient under guardianship or curatorship \* if applicable according to local regulation
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Hôpital privé Aix en provence | Aix-en-Provence, France | Recruiting |
| Clinique Saint vincent | Besançon, France | Recruiting |
| Hôpital Civil Colmar | Colmar, France | Recruiting |
| Hôpital Edouard Heriot | Lyon, France | Recruiting |
| Clinique Nantes Atlantis | Nantes, France | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.